POSTER ABSTRACTS P55 PLASMA LEVONORGESTREL LEVELS FROM 72 TO 96 MONTHS IN OBESE AND NON-OBESE WOMEN USING A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM

Autor: Creinin, Starr, RM, Olariu, AI

Publikováno v: Contraception, vol 104, iss 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::310bd997d410399a8dc7e551e6640b80
https://escholarship.org/uc/item/64x156r0

Return of fertility in nulliparous and parous women after levonorgestrel 52 mg intrauterine system discontinuation

Autor: Carr, BR, Thomas, MA, Gangestad, A, Eisenberg, DL, Olariu, AI, Creinin, MD

Publikováno v: Fertility and Sterility, vol 110, iss 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4fc9498452b8de08696d2cbf1d769ffc
https://escholarship.org/uc/item/1s1994f3

POSTER ABSTRACTS: P55 PLASMA LEVONORGESTREL LEVELS FROM 72 TO 96 MONTHS IN OBESE AND NON-OBESE WOMEN USING A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM

Autor: Creinin, MD, Starr, RM, Olariu, AI

Publikováno v: In Contraception October 2021 104(4):464-464

Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].

Autor: Creinin MD; Division of Family Planning, Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA., Schreiber CA; Division of Family Planning, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA., Turok DK; Division of Family Planning, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT., Cwiak C; Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA., Chen BA; Division of Gynecologic Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, PA., Olariu AI; Medicines 360, San Francisco, CA.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2023 Sep; Vol. 229 (3), pp. 358. Date of Electronic Publication: 2023 Jul 24.

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.

Autor: Creinin MD; Division of Family Planning, Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA. Electronic address: mdcreinin@ucdavis.edu., Schreiber CA; Division of Family Planning, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA., Turok DK; Division of Family Planning, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT., Cwiak C; Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA., Chen BA; Division of Gynecologic Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, PA., Olariu AI; Medicines360, San Francisco, CA.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2022 Dec; Vol. 227 (6), pp. 871.e1-871.e7. Date of Electronic Publication: 2022 May 13.